期刊文献+

垂体大腺瘤临床及MRI特点在不同性别间的比较 被引量:2

Comparison of clinical and MRI characteristics of pituitary macroadenoma between different genders
下载PDF
导出
摘要 目的比较男性和女性垂体大腺瘤的临床及MRI特点。方法230例(男104例,女126例)经病理证实的垂体大腺瘤患者按性别分为两组,分别计算每组的平均年龄、瘤体内出血和海绵窦受累的比率、肿瘤体积,并进行组间比较,同时比较两组病例的病理类型构成。结果男性组年龄、瘤内出血率、海绵窦受累率及肿瘤体积分别为(44.8±13.2)岁、21.15%(22/104)、50.00%(52/104)及6100.48mm3;女性组分别为(44.8±11.9)岁、28.57%(36/126)、48.41%(61/126)及5037.05mm3。两组病例的年龄、瘤内出血率、海绵窦受累率、肿瘤体积及病理类型构成无统计学差异(P=0.972,P=0.197,P=0.811,P=0.189,P=0.093)。结论垂体大腺瘤的临床及MRI特点无性别差异。 Objective To compare the clinical and MRI characteristics of pituitary macroadenoma between male and female patients. Methods Two hundred and thirty patients with pathologically diagnosed pituitary macroadenomas (104 mlaes and 126 females) were divided into two groups according to different gender. Patient age, the ratio of intratumoral hemorrhage and cavernous sinus invasion, and tumor volume were calculated in each group and compared between the two groups. The constitution of different pathological types was also compared. Results The age, ratio of intratumoral hemorrhage and cavernous sinus invasion, and tumor volume was (44.8±13.2) years old, 21.15% (22/104), 50.00% (52/104), and 6100.48 (mm^3 , median) in the male group and (44.8±11.9) years old, 28.57% (36/126), 48.41% (61/126) and 5037.05 (mm^3 , median) in the female group, respectiveluy. There was no statistical difference between the two groups regarding to patient age, the ratio of intratumoral hemorrhage and cavernous sinus invasion, tumor volume, and constitution of pathological types (P=0. 972, P=0. 197, P=0. 811, P=0. 189, P=0. 093, respectively). Conclusion Pituitary macroadenomas show no gender preference in clinical and MRI characteristics.
出处 《中国医学影像技术》 CSCD 北大核心 2010年第2期234-237,共4页 Chinese Journal of Medical Imaging Technology
基金 "十一五"国家科技支撑计划重点项目(2007BAI05B08)
关键词 垂体大腺瘤 性别 出血 海绵窦 磁共振成像 Pituitary macroadenoma Gender Hemorrhage Cavernous sinus Magnetic resonance imaging
  • 相关文献

参考文献15

  • 1Gong J, Zhao Y, Abdel-Fattah R, et al. Matrix metalloproteinase- 9, a potential biological marker in invasive pituitary adenomas. Pituitary, 2008,11(1) :37-48.
  • 2Osamura RY, Kajiya H, Takei M, et al. Pathology of the human pituitary adenomas. Histochem Cell Biol, 2008,130(3):495-507.
  • 3Kontogeorgos G. Predictive markers of pituitary adenoma behavior. Neuroendocrinology, 2006,83(3- 4):179- 188.
  • 4Ferreira JE, de Mello PA, de Magalhaes AV, et al. Non-funetio ning pituitary adenomas: Clinical features and immunohistochemistry. Arq Neuropsiquiatr, 2005,63(4) : 1070-1078.
  • 5Qian ZR, Sano T, Asa SL, et al. Cytoplasmic expression of fibroblast growth factor receptor-4 in human pituitary adenomas: relation to tumor type, size, proliferation, and invasiveness. J Clin Endocrinol Metab, 2004,89(4) : 1904-1911.
  • 6Goh KP, Lee HY, Rajasoorya RC. Triple jeopardy in the pituitary. Pituitary, 2008,11(3) :331-336.
  • 7Semple PL, Jane JA, Lopes MB, et al. Pituitary apoplexy: correlation between magnetic resonance imaging and histopathological results. J Neurosurg, 2008, 108(5) :909-915.
  • 8Cottier JP, Destrieux C, Brunereau L, et al. Cavernous sinus invasion by pituitary adenoma: MR imaging. Radiology, 2000, 215 (2) :463-469.
  • 9Stadlbauer A, Buchfelder M, Nimsky C, et al. Proton magnetic resonance spectroscopy in pituitary macroadenomas: Preliminary results. J Neurosurg, 2008,109(2) :306-312.
  • 10Buurman H, Saeger W. Subclinical adenomas in postmortem pituitaries : classification and correlations to clinical data. Eur J Endocrinol, 2006, 154(5) :753-758.

二级参考文献31

共引文献19

同被引文献14

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部